Lv11
20 积分 2024-08-30 加入
Non-clinical pharmacology and toxicology studies of bevacizumab biosimilar LY01008
5小时前
待确认
Historical Overview of Regulatory Approvals and PMDA Assessments for Biosimilar Products in Japan During 2009–2022
5小时前
求助中
Streamlining biosimilar development based on 20 years’ experience
21天前
已完结
Promising strategies for improving oral bioavailability of poor water-soluble drugs
4个月前
已完结
Glycogen accumulation and phase separation drives liver tumor initiation
4个月前
已完结
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
4个月前
已完结
Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases
4个月前
已完结
Structure dependence and species sensitivity of in vivo hepatobiliary toxicity with lysophosphatidic acid receptor 1 (LPA1) antagonists
4个月前
已完结
The Application and Pharmaceutical Development of Etomidate: Challenges and Strategies
4个月前
已完结
The Application and Pharmaceutical Development of Etomidate: Challenges and Strategies
5个月前
已完结
皖公网安备34019202002308
